Real programs. Real validation data.
Client identities are anonymized at their request, but every metric below is from a closed engagement with downstream wet-lab expression and functional confirmation.
- 70–85%
- Average cost reduction
- 4–6×
- Average time savings
- 72%
- Expression success (top 50)
- 100%
- On-time delivery rate
Three programs across biologics modalities
Select a case study to read the full engagement timeline, ranked deliverables, validation outcomes, and lessons learned.
Neutralizing Antibody Discovery Against RSV F-Protein Prefusion State
Vaccine biotech needed developable neutralizing antibodies against respiratory syncytial virus for a passive immunization program.
- 4 wks
- Computational delivery
- 340×
- Larger search vs. phage display
HER2 Bispecific T-Cell Engager Design for Solid Tumor Immunotherapy
Clinical-stage oncology biotech needed a developable HER2×CD3 bispecific with controlled cytokine release profile before IND-enabling studies.
- 5 wks
- Computational delivery
- 82%
- Developability pass rate (top 30)
Industrial Enzyme Thermostability Engineering for High-Temperature Bioprocessing
Industrial biotech needed a cellulase variant stable above 75°C for a next-generation biofuel pretreatment line.
- 3 wks
- Computational delivery
- +22°C
- ΔTm on lead variant
Your program could be the next case study.
Tell us about your antigen or protein engineering challenge. We will scope a 2 to 4 week pilot.